Thyroid carcinomas with a variable insular component: Prognostic significance of histopathologic patterns

Cancer

Volumn 110, Issue 6, 2007, Pages 1209-1217

  Rufini, Vittoria ^a,c   Salvatori, Massimo ^a   Fadda, Guido ^a   Pinnarelli, Luigi ^b   Castaldi, Paola ^a   Maussier, Maria Lodovica ^a   Galli, Guido ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b SAN FILIPPO NERI HOSPITAL   (Italy)

^c FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Histopathology; Insular carcinoma; Prognosis; Survival; Thyroid

Indexed keywords

IODINE 131;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLICULAR CARCINOMA; FOLLOW UP; HUMAN; MALE; METASTASIS; PAPILLARY CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SURVIVAL RATE; THYROID CARCINOMA; TREATMENT OUTCOME; TUMOR VOLUME;

AGED; CARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; THYROID NEOPLASMS;

EID: 34548760325     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22913     Document Type: Article

References (34)

1. Carcangiu ML, Zampi G, Rosai J. Poorly differentiated ("insular") thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma." Am J Surg Pathol. 1984;8:655-668.
2. Pilotti S, Collini P, Mariani L, et al. Insular carcinoma: a distinct de novo entity among follicular carcinomas of the thyroid gland. Am J Surg Pathol. 1997;21:1466-1473.
3. Ashfaq R, Vuitch F, Delgado R, Albores-Saavedra J. Papillary and follicular thyroid carcinomas with an insular component. Cancer. 1994;73:416-4123.
4. Papotti M, Botto Micca F, Favero A, Palestini N, Bussolati G. Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol. 1993;17:291-301.
5. Van den Brekel MWM, Hekkenberg RJ, Asa SL, Tomlinson G, Rosen IB, Freeman JL. Prognostic features in tall cell papillary carcinoma and insular thyroid carcinoma. Laryngoscope. 1997;107:254-259.
6. Pellegrini G, Giuffrida D, Scollo C, et al. Long-term outcome of patients with insular carcinoma of the thyroid. The insular histotype is an independent predictor of poor prognosis. Cancer. 2002;95:2076-2085.
7. Rosai J, Carcangiu ML, De Lellis RA. Tumors of the thyroid gland. 3rd series. Washington, DC: Armed Forces Institute of Pathology; 1993.
8. Sazaki A, Daa T, Kashima K, Yokoyama S, Nakayama I, Noguchi S. Insular component as a risk factor of thyroid carcinoma. Pathol Int. 1996;46:939-946.
9. Nishida T, Katayama S, Tsujimoto M, Nakamura J, Matsuda H. Clinicopathological significance of poorly differentiated thyroid carcinoma. Am J Surg Pathol. 1999;23:205-211.
10. Volante M, Landolfi S, Chiusa L, et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular and solid patterns. A clinicopathologic study of 183 patients. Cancer. 2004;100:950-957.
11. Sobin LH, Wittekind C, editors. TNM Classification of Malignant Tumors. 6th ed. New York: John Wiley & Sons; 2002.
12. Greene FL, Page DL, Fleming ID, et al., editors. Thyroid. In: Greene FL, Page DL, Fleming ID, et al., editors. AJCC Cancer Staging Manual. 6th ed. New York: Springer, 2002:89-98.
13. Rufini V, Salvatori M, Saletnich I, et al. Disseminated bone marrow metastases of insular thyroid carcinoma detected by radioiodine whole-body scintigraphy. J Nucl Med. 1996;37:633-636.
14. Albareda M, Puig-Domingo M, Wengrowicz S, et al. Clinical forms of presentation and evolution of diffuse sclerosing variant of papillary carcinoma and insular variant of follicular carcinoma of the thyroid. Thyroid. 1998;8:385-391.
15. Flynn SD, Formann BH, Stewart AF, Kinder BK. Poorly differentiated (insular) carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms. Surgery. 1988;104:963-970.
16. Decaussin M, Bernard MH, Adeleine R et al. Thyroid carcinoma with distant metastases. A review of 111 cases with emphasis in the prognostic significance of an insular component. Am J Surg Pathol. 2002;26:1007-1015.
17. Machens A, Hinze R, Lautenschlager C, Dralle H. Multivariate analysis of clinicopathologic parameters for the insular subtype of differentiated thyroid carcinoma. Arch Surg. 2001;136:941-944.
18. Albores-Saavedra J, Housini I, Vuitch F, Snyder WH 3rd. Macrofollicular variant of papillary thyroid carcinoma with minor insular component. Cancer. 1997;80:1110-1116.
19. Baloch ZW, LiVolsi V. Prognostic factors in well-differentiated follicular-derived carcinoma and medullary thyroid carcinoma. Thyroid. 2001;11:637-645.
20. Pacini F, Schlumberger M, Dralle H, et al. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. Eur J Endocrinol. 2006;154:787-803.
21. Hassoun AA, Hay ID, Goellner JR, Zimmerman D. Insular thyroid carcinoma in adolescents: a potentially lethal endocrine malignancy. Cancer. 1997;79:1044-1048.
22. Lo CY, Lam KY, Wan KY. Insular thyroid carcinoma in adolescents. Eur J Surg. 2000;166:585-587.
23. Zettinig G, Kaerer K, Passler C, et al. Advanced insular thyroid carcinoma in a fourteen-year-old girl: twenty-four years of follow-up. Thyroid. 2000;10:435-437.
24. Jusuf K, Reyes-Mugica M, Carpenter TO. Insular carcinoma of the thyroid in an adolescent: a case report and review of the literature. Curr Opin Pediatr. 2003;15:512-515.
25. Rijhwani A, Satish GN. Insular carcinoma of the thyroid in a 10-year-old child. J Pediatr Surg. 2003;38:1083-1085.
26. Prommegger R, Haussler B, Gabriel M, et al. Insular-type component follicular thyroid carcinoma in a 10-year-old girl. Case report. J Pediatr Surg. 2006;41:E5-E7.
27. Sobrinho-Simoes M. Poorly differentiated thyroid carcinomas. Endocrine Pathol. 1996;2:99-102.
28. Nishiyama RH. Another dissertation on poorly differentiated carcinomas: is it really necessary? Adv Anat Pathol. 1999;6:281-286.
29. Durante C, Haddy N, Baudin E, et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91:2892-2899.
30. Wang W, Larson SM, Tuttle RM, et al. Resistance of [18F]- fluoredeoxyglcose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine. Thyroid. 2001;11:1169-1175.
31. 18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning. J Clin Endocrinol Metab. 2006;91:498-505.
32. Santoro M, Papotti M, Chiappetta G, et al. RET activation and clinicopathologic features in poorly differentiated thyroid tumors. J Clin Endocrinol Metab. 2002;87:370-379.
33. Takeuchi Y, Daa T, Kashima K, Yokoyama S, Nakayama I, Noguchi S. Mutations of p53 in thyroid carcinoma with an insular component. Thyroid. 1999;9:377-381.
34. Lam KY, Lo CY Chan KW, Wan KY. Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21. Ann Surg. 2000;231:329-338.